Page last updated: 2024-10-27

flurbiprofen and Esophageal Squamous Cell Carcinoma

flurbiprofen has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Esophageal Squamous Cell Carcinoma: A carcinoma that originates usually from cells on the surface of the middle and lower third of the ESOPHAGUS. Tumor cells exhibit typical squamous morphology and form large polypoid lesions. Mutations in RNF6, LZTS1, TGFBR2, DEC1, and WWOX1 genes are associated with this cancer.

Research Excerpts

ExcerptRelevanceReference
"The present study evaluated whether flurbiprofen increased the naturally circulating dendritic cells (DCs) subsets in patients with esophageal squamous cell carcinoma (ESCC) undergoing esophageal resection."5.22A short-term increase of the postoperative naturally circulating dendritic cells subsets in flurbiprofen-treated patients with esophageal carcinoma undergoing thoracic surgery. ( Chai, XQ; Shu, SH; Wang, D; Wei, W; Wei, X; Wu, YJ; Xie, YH; Yang, XL; Zhang, XL, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, D1
Yang, XL1
Chai, XQ1
Shu, SH1
Zhang, XL1
Xie, YH1
Wei, X1
Wu, YJ1
Wei, W1

Trials

1 trial available for flurbiprofen and Esophageal Squamous Cell Carcinoma

ArticleYear
A short-term increase of the postoperative naturally circulating dendritic cells subsets in flurbiprofen-treated patients with esophageal carcinoma undergoing thoracic surgery.
    Oncotarget, 2016, Apr-05, Volume: 7, Issue:14

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Case-Control Studies; Cytok

2016